Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.85%||180.99||0.7%||$1263.76m|
|BMY||Bristol-Myers Squibb Co.||-1.86%||76.15||1.0%||$1200.63m|
|MRK||Merck & Co., Inc.||0.77%||93.02||0.7%||$1171.65m|
|LLY||Eli Lilly & Co.||3.15%||323.34||1.1%||$1017.85m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||0.15%||143.40||0.0%||$499.78m|
|SIGA||SIGA Technologies, Inc.||41.91%||13.68||0.0%||$209.92m|
|HZNP||Horizon Therapeutics Plc||4.69%||94.84||5.4%||$209.26m|
|NVO||Novo Nordisk A/S||1.07%||107.74||0.1%||$184.03m|
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.